Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ... Read More

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston Scientific (BSX) closed at $104.33 in the latest trading session, marking a +1.09% move from the prior day. This change outpaced the S&P 500's 0.14% gain on the day. Elsewhere, the Dow gained 0 ... Read More

Boston Scientific price target raised to $100 from $86 at TD Cowen

TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $100 from $86 and keeps a Buy rating on the shares. The firm believes they will beat the Street’s 3Q estimates and once ... Read More

BTIG Sticks to Its Buy Rating for Boston Scientific (BSX)

BTIG analyst Marie Thibault maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $120.00. The company’s shares opened today at $102.94. Leverage ... Read More

Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

Boston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other ... Read More

Piper Sandler Keeps Their Buy Rating on Boston Scientific (BSX)

In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $95.00. The company’s shares ... Read More

Boston Scientific (BSX) Stock: Price Correction Coming

Learn why I believe that a price correction is coming for BSX stock. ... The market is overreacting to recent news. ... Right now, Boston Scientific has over $8.5 billion in debt despite having ... Read More

What’s Next For Boston Scientific Stock After Outperforming During ...

BSX stock declined from $14 in September 2007 (pre-crisis peak) to around $7 in March 2009 (as the markets bottomed out), implying it lost nearly 50% of its pre-crisis value. Read More

What’s Behind The 130% Rise In Boston Scientific Stock? - Forbes

So far, BSX stock has risen 19% year-to-date. Boston Scientific’s revenue climbed 32%, rising from $12.7 billion in 2022 to $16.7 billion in 2024, driven by an increase in total procedures and ... Read More

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston Scientific (BSX) closed the most recent trading day at $91.07, moving +1.35% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 1.1% ... Read More